Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

1
Player Avatar lola99999 (< 20) Submitted: 12/16/2009 9:33:21 PM : Outperform Start Price: $2.57 ARRY Score: +15.32

ARRY

Featured Broker Partners


Advertisement